key: cord-0892546-smnqpt9e
authors: Sánchez, Andrea Severo; Rey, Juan R.; Iniesta, Ángel Manuel; Merino, Jose L.; Castrejón-Castrejón, Sergio; López-de-Sá, Esteban; Caro-Codón, Juan
title: Heart rate at presentation of COVID-19: Can SARS-CoV-2 be a cause of dysautonomia?
date: 2021-11-20
journal: Rev Port Cardiol
DOI: 10.1016/j.repc.2021.07.010
sha: 30a3f9f76a9abc0dba7676ff3006d5be805069bc
doc_id: 892546
cord_uid: smnqpt9e

nan

Respiratory infections usually lead to a physiological response mediated by the autonomic nervous system, which generally includes some degree of tachycardia. Our aim was to investigate the autonomic response in patients with COVID-19 based on the relationship between heart rate (HR), temperature (Tª) and oxygen saturation (SatO2) in the initial assessment at the emergency department. This is a retrospective, single-center study based on a large cohort of consecutive patients with confirmed diagnosis of SARS-CoV-2 infection by polymerase chain reaction, conducted from 1 March to 20 April 2020 in a tertiary hospital in Madrid (Spain).

A total of 2757 patients (53.9% male, mean age 64.215.6 years) were included in the present analysis (detailed baseline characteristics are shown in Table 1 ). Among them, 78.1% required hospital admission, with 6.5% requiring admission to critical care units. Figure 1A ). Although the proportion of HR lowering drugs was higher in this group, the results were similar in those patients who did not take them.

A more detailed analysis showed that HR did not have a significant correlation with SatO2 at admission (Pearson's correlation coefficient -0.01, p=0.596, Figure 1B ), although it did reveal a weak significant correlation with temperature (Pearson's correlation coefficient 0.155, p<0.001, Figure 1C ).

Since the beginning of the pandemic, multiple neurological manifestations of SARS-CoV-2 infection have been described, ranging from anosmia or dysgeusia to more serious conditions such as Guillain-Barré. However, evidence about its ability to cause dysautonomia is lacking. Although dysautonomia is linked to chronic diseases such as diabetes or Parkinson, cases associated with viral infections (including human immunodeficiency virus, hepatitis C, Epstein-Barr virus or Coxsackie) have also been described. Several studies have demonstrated that SARS-CoV-2 may affect the nervous system, with a special affinity for the medullary structures and the brainstem. Both areas show a strong expression of angiotensin-converting-enzyme-2 and are closely linked to the autonomic nervous system and interoception. 1 One of the most surprising aspects of COVID-19 pneumonia is the lack of dyspnea in patients with very low levels of blood oxygen. Some authors use the term "happy hypoxemia" to describe this dissociation. In the Wuhan cohort, only 19% of the patients infected with SARS-CoV2 reported dyspnea; 62% of the patients with severe disease (and approximately half of those who were intubated, ventilated, or died) did not present with dyspnea. 2, 3 In our setting, the proportion of patients with dyspnea was less than 50%. 4 Besides, also in favor of COVID-19-associated dysautonomia, cases of relative bradycardia (inappropriately low HR in response to an increase in temperature) have been described, Although more studies are needed, dysautonomia must not delay appropriate management of COVID-19 patients (in the case of hypoxia-dyspnea dissociation). In fact, it may signal clinical worsening. 

Dysautonomia: An Overlooked Neurological Manifestation in a Critically ill COVID-19 Patient

Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis

Clinical characteristics of Coronavirus disease 2019 in China

A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe

Relative bradycardia in patients with coronavirus disease 2019 (COVID-19)

Bradycardia in Patients With COVID-19: A Calm Before the Storm? Cureus